On Nov. 24, South Africa told the World Health Organization that amid a recent increase in COVID-19 cases, it had identified a new variant — later named omicron — with a high number of mutations, raising concerns that it could spread more easily than other variants of the coronavirus. We’ll go through what we know so far about omicron.
Stories by Jessica McDonald
Benefits Outweigh Risks of Pediatric COVID-19 Vaccine, Contrary to Posts Misusing VAERS Data
Pfizer/BioNTech’s COVID-19 Vaccine Formulation Tweaked to Improve Stability
With the release of its pediatric COVID-19 vaccine, Pfizer switched the buffer used in its formulation to increase the stability of the product, allowing it to remain at refrigerator temperatures for longer. The Food and Drug Administration OK’d the change, which is also being made to some doses for teens and adults. Social media posts, however, misleadingly suggest that the ingredient swap is dangerous or was added to prevent heart attacks in children.
Aaron Rodgers’ Inaccurate COVID-19 Claims
A Guide to Pfizer/BioNTech’s Pediatric COVID-19 Vaccine for Kids 5-11
Republicans Spin NIH Letter About Coronavirus Gain-of-Function Research
Republicans say a letter from a National Institutes of Health official is an admission that the agency funded so-called gain-of-function research on bat coronaviruses in China, with some falsely linking the work to the pandemic coronavirus. But the research, which the NIH maintains is not gain-of-function, could not have led to SARS-CoV-2, the virus that causes COVID-19.
Colin Powell’s COVID-19 Death Followed Cancer Diagnosis, Treatment
Former Secretary of State Colin Powell died from complications of COVID-19. Although he was fully vaccinated, he was also 84 years old and was a cancer patient who had undergone treatment for multiple myeloma — factors that put him at higher risk of a serious breakthrough illness. His death does not mean the COVID-19 vaccines don’t work, as many social media posts suggest.
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.
Biden’s Controversial COVID-19 Vaccine Booster Plan
CDC Document Discusses Strategy To Protect Displaced People From COVID-19
A Centers for Disease Control and Prevention document reviews the challenges of using a “shielding” approach to protect high-risk people living in places such as refugee camps from COVID-19. But conservative commentator Candace Owens misinterpreted it to mean the agency was proposing putting high-risk Americans into camps.